Tue, Aug 4, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Fund of funds face new challenges from investors

Thursday, February 06, 2014

Bailey McCann, Opalesque New York:

Fund of funds in the US and Europe have been dealing with headwinds ever since 2008. As regulation and investor's preference for direct investing has evolved the fee structure and access offered by the fund of funds model makes less sense to savvy institutions. Delegates at the recent Opalesque Geneva Roundtable noted that fund of funds in America are getting bigger mandates, at least in part because of their willingness to carve out niche expertise.

"In the fund of funds industry, the core business relies upon the selection of the most talented hedge fund managers. We all know that. But what the industry players have been figuring out over the last couple of years is that it is no longer enough from an investor standpoint. Fund of funds managers now need to go beyond that, for instance by convincing a manager to evolve under a UCITS format or by being responsible vis-à-vis the fee structure. On this last point, I must stress that I believe that the 2 and 20 structure, especially in Europe, is no longer acceptable," explains Arié Assayag, Global CEO of UBP Alternative Investments.

This focus on fees in Europe may be putting investors at a disadvantage over their American counterparts. "The industry is facing this significant demand from mostly U.S. pension funds or endowments that are going direct. Those institutions basically seem not to care s......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner